IFG Advisory’s Inovio Pharmaceuticals INO Stock Holding History

IFG Advisory’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$917	Buy	+833	New	+$988	﹤0.01%	2202
2024 Q1	–	Sell	-833	Closed	-$5.1K	–	473
2023 Q4	$5.1K	Hold	833	–	–	﹤0.01%	576
2023 Q3	$3.89K	Hold	833	–	–	﹤0.01%	537
2023 Q2	$4.46K	Hold	833	–	–	﹤0.01%	323
2023 Q1	$8.2K	Sell	833 -137	-14%	-$2.33K	﹤0.01%	509
2022 Q4	$18K	Hold	970	–	–	﹤0.01%	486
2022 Q3	$20K	Hold	970	–	–	﹤0.01%	512
2022 Q2	$20K	Hold	970	–	–	﹤0.01%	458
2022 Q1	$41K	Buy	970 +87	+10%	+$3.92K	﹤0.01%	486
2021 Q4	$52K	Hold	883	–	–	0.01%	494
2021 Q3	$75K	Hold	883	–	–	0.01%	476
2021 Q2	$98K	Buy	+883	New	+$84.8K	0.01%	467
2020 Q3	–	Sell	-9,770	Closed	-$3.16M	–	413
2020 Q2	$3.16M	Buy	9,770 +4	+0%	+$642	0.57%	41
2020 Q1	$871K	Buy	+9,766	New	+$602K	0.19%	126

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IFG Advisory's INO Position: Q2 2026 in Review

IFG Advisory opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 833 shares worth $917. The stake represents ﹤0.01% of the portfolio and ranks #2202 among its holdings. This is a return to the name: IFG Advisory previously reported a position in INO as recently as Q4 2023.

IFG Advisory first reported a position in INO in Q1 2020 and has held it in 14 quarters since. The position peaked at $3.16M in Q2 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

IFG Advisory held 833 shares of Inovio Pharmaceuticals worth $917 as of Q2 2026.
Inovio Pharmaceuticals was a new IFG Advisory position in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of IFG Advisory's portfolio in Q2 2026, its #2202 holding.
IFG Advisory first reported a position in Inovio Pharmaceuticals in Q1 2020 and has held it in 14 quarters since.
IFG Advisory's Inovio Pharmaceuticals position peaked at $3.16M in Q2 2020.
103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.